Alpine Woods Capital Investors LLC Sells 331 Shares of Intuitive Surgical, Inc. $ISRG

Alpine Woods Capital Investors LLC cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,519 shares of the medical equipment provider’s stock after selling 331 shares during the quarter. Intuitive Surgical accounts for 1.4% of Alpine Woods Capital Investors LLC’s holdings, making the stock its 21st largest position. Alpine Woods Capital Investors LLC’s holdings in Intuitive Surgical were worth $5,716,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Chilton Capital Management LLC increased its holdings in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. bought a new position in shares of Intuitive Surgical during the first quarter worth approximately $26,000. LFA Lugano Financial Advisors SA bought a new position in shares of Intuitive Surgical during the first quarter worth approximately $30,000. TD Capital Management LLC increased its holdings in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the period. Finally, 1248 Management LLC bought a new position in shares of Intuitive Surgical during the first quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 over the last quarter. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $435.73 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a market capitalization of $156.20 billion, a P/E ratio of 60.77, a P/E/G ratio of 4.51 and a beta of 1.61. The company’s 50 day moving average price is $457.73 and its two-hundred day moving average price is $497.44.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter last year, the business posted $1.78 earnings per share. The company’s quarterly revenue was up 21.4% on a year-over-year basis. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ISRG shares. BTIG Research lowered their target price on shares of Intuitive Surgical from $571.00 to $529.00 and set a “buy” rating on the stock in a report on Monday. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, October 4th. The Goldman Sachs Group decreased their price objective on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday, October 1st. Finally, Piper Sandler reissued an “overweight” rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $584.76.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.